• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沃克酰胺-阿莫西林联合益生菌根除治疗对口腔微生物群的影响:一项随机双盲安慰剂对照试验。

The impact of eradication with vonoprazan-amoxicillin dual therapy combined with probiotics on oral microbiota: a randomized double-blind placebo-controlled trial.

作者信息

Peng Ruolin, Zhang Zhenyu, Qu Yi, Chen Weiwei

机构信息

Department of Gastroenterology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.

出版信息

Front Microbiol. 2023 Oct 2;14:1273709. doi: 10.3389/fmicb.2023.1273709. eCollection 2023.

DOI:10.3389/fmicb.2023.1273709
PMID:37849923
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10577438/
Abstract

BACKGROUND

infection and eradication have been reported to cause dysbiosis of the oral microbiota. Probiotics are increasingly being used to maintain the balance of the oral microbiota. We aimed to investigate the effects of infection, eradication with vonoprazan-amoxicillin dual therapy, and probiotics supplementation on the oral microbiota.

METHODS

positive patients were randomly assigned to a vonoprazan-amoxicillin regimen plus probiotics (BtT group) or the placebo (PT group) for 14 days. negative population served as normal controls. Tongue coating samples were collected from 60 positive patients at three time points (before eradication, after eradication, and at confirmation of infection cure) and 20 negative subjects. 16S rRNA gene sequencing was used to analyze the oral microbiota.

RESULTS

was detected in the oral cavity in positive (34/60), negative (7/20), and eradicated (1/60) subjects using high-throughput sequencing. Compared with normal controls, positive patients exhibited higher richness ( = 0.012) and comparable diversity ( = 0.075) of oral microbiota. Beta diversity and KEGG analysis showed oral flora composition and function differences in positive and negative subjects. Alpha diversity dramatically decreased after eradication and modestly increased with confirmation of eradication. Beta diversity and LEfSe analysis revealed distinct structures, and KEGG analysis showed distinct signaling pathways of tongue coating flora at three time points. There was a significant reduction of Firmicutes and after erdication. The PT group and BtT group had identical compositional and functional differences of oral microbiota at three time points.

CONCLUSION

No substantial link existed between oral and stomach , while removing gastric helped eliminate oral . infection and vonoprazan-amoxicillin dual therapy affected oral microbiota diversity, structure, and function. eradication demonstrated a suppressive impact on the proliferation of oral pathogens, specifically Firmicutes and . Nevertheless, probiotics supplementation did not reduce the oral microbial disturbance caused by eradication.

CLINICAL TRIAL REGISTRATION

https://www.chictr.org.cn/, identifiers CHICTR2200060023.

摘要

背景

据报道,幽门螺杆菌感染及根除会导致口腔微生物群失调。益生菌越来越多地被用于维持口腔微生物群的平衡。我们旨在研究幽门螺杆菌感染、沃克帕唑-阿莫西林联合疗法根除幽门螺杆菌以及补充益生菌对口腔微生物群的影响。

方法

幽门螺杆菌阳性患者被随机分为沃克帕唑-阿莫西林方案加益生菌组(BtT组)或安慰剂组(PT组),治疗14天。幽门螺杆菌阴性人群作为正常对照。在三个时间点(根除前、根除后以及确认幽门螺杆菌感染治愈时)从60例幽门螺杆菌阳性患者和20例阴性受试者中采集舌苔样本。采用16S rRNA基因测序分析口腔微生物群。

结果

通过高通量测序在幽门螺杆菌阳性(34/60)、阴性(7/20)和根除(1/60)受试者的口腔中检测到幽门螺杆菌。与正常对照相比,幽门螺杆菌阳性患者口腔微生物群的丰富度更高(P = 0.012),多样性相当(P = 0.075)。β多样性和KEGG分析显示幽门螺杆菌阳性和阴性受试者的口腔菌群组成和功能存在差异。根除幽门螺杆菌后α多样性显著降低,确认根除后略有增加。β多样性和LEfSe分析揭示了三个时间点舌苔菌群的不同结构,KEGG分析显示了不同的信号通路。根除幽门螺杆菌后厚壁菌门和幽门螺杆菌显著减少。PT组和BtT组在三个时间点口腔微生物群的组成和功能差异相同。

结论

口腔和胃中的幽门螺杆菌之间不存在实质性联系,而清除胃内幽门螺杆菌有助于消除口腔中的幽门螺杆菌。幽门螺杆菌感染和沃克帕唑-阿莫西林联合疗法影响口腔微生物群的多样性、结构和功能。根除幽门螺杆菌对口腔病原体,特别是厚壁菌门和幽门螺杆菌的增殖有抑制作用。然而,补充益生菌并不能减少根除幽门螺杆菌引起的口腔微生物紊乱。

临床试验注册

https://www.chictr.org.cn/,标识符CHICTR2200060023。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e4d/10577438/6ca275cac775/fmicb-14-1273709-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e4d/10577438/ebc97d1eb67d/fmicb-14-1273709-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e4d/10577438/6148edb419ec/fmicb-14-1273709-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e4d/10577438/dc5a232ea82b/fmicb-14-1273709-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e4d/10577438/34c0d27d1525/fmicb-14-1273709-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e4d/10577438/20e9deb87cfe/fmicb-14-1273709-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e4d/10577438/9668e8bcdc13/fmicb-14-1273709-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e4d/10577438/6ca275cac775/fmicb-14-1273709-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e4d/10577438/ebc97d1eb67d/fmicb-14-1273709-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e4d/10577438/6148edb419ec/fmicb-14-1273709-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e4d/10577438/dc5a232ea82b/fmicb-14-1273709-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e4d/10577438/34c0d27d1525/fmicb-14-1273709-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e4d/10577438/20e9deb87cfe/fmicb-14-1273709-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e4d/10577438/9668e8bcdc13/fmicb-14-1273709-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e4d/10577438/6ca275cac775/fmicb-14-1273709-g007.jpg

相似文献

1
The impact of eradication with vonoprazan-amoxicillin dual therapy combined with probiotics on oral microbiota: a randomized double-blind placebo-controlled trial.沃克酰胺-阿莫西林联合益生菌根除治疗对口腔微生物群的影响:一项随机双盲安慰剂对照试验。
Front Microbiol. 2023 Oct 2;14:1273709. doi: 10.3389/fmicb.2023.1273709. eCollection 2023.
2
Analysis of oral microbiota alterations induced by Helicobacter pylori infection and vonoprazan-amoxicillin dual therapy for Helicobacter pylori eradication.分析幽门螺杆菌感染引起的口腔微生物群改变和沃诺拉赞-阿莫西林双联疗法根除幽门螺杆菌的效果。
Helicobacter. 2022 Oct;27(5):e12923. doi: 10.1111/hel.12923. Epub 2022 Aug 29.
3
Altered Gut Microbiota and Short-Chain Fatty Acids After Vonoprazan-Amoxicillin Dual Therapy for Eradication.**标题**:**沃诺拉赞-阿莫西林双联疗法根除后肠道微生物群和短链脂肪酸的变化** **原文**:Altered Gut Microbiota and Short-Chain Fatty Acids After Vonoprazan-Amoxicillin Dual Therapy for Eradication. **译文**:沃诺拉赞-阿莫西林双联疗法根除后肠道微生物群和短链脂肪酸的变化。
Front Cell Infect Microbiol. 2022 Jun 2;12:881968. doi: 10.3389/fcimb.2022.881968. eCollection 2022.
4
Probiotics modulate gastrointestinal microbiota after eradication: A multicenter randomized double-blind placebo-controlled trial.益生菌可调节根除治疗后的胃肠道微生物群:一项多中心随机双盲安慰剂对照试验。
Front Immunol. 2022 Nov 8;13:1033063. doi: 10.3389/fimmu.2022.1033063. eCollection 2022.
5
The impact of Helicobacter pylori infection, eradication therapy, and probiotics intervention on gastric microbiota in young adults.幽门螺杆菌感染、根除治疗和益生菌干预对年轻成年人胃微生物群的影响。
Helicobacter. 2021 Dec;26(6):e12848. doi: 10.1111/hel.12848. Epub 2021 Aug 26.
6
Lower impact of vonoprazan-amoxicillin dual therapy on gut microbiota for Helicobacter pylori eradication.vonoprazan-阿莫西林双联疗法对幽门螺杆菌根除治疗中肠道微生物群的影响较小。
J Gastroenterol Hepatol. 2021 Dec;36(12):3314-3321. doi: 10.1111/jgh.15572. Epub 2021 Jun 20.
7
Effects of Helicobacter pylori and Helicobacter pylori eradication on the microbiota of tongue coating.舌涂层中幽门螺杆菌和幽门螺杆菌根除对微生物群的影响。
BMC Microbiol. 2024 Oct 18;24(1):416. doi: 10.1186/s12866-024-03584-y.
8
The efficacy of Lactobacillus acidophilus and rhamnosus in the reduction of bacterial load of Helicobacter pylori and modification of gut microbiota-a double-blind, placebo-controlled, randomized trial.嗜酸乳杆菌和鼠李糖乳杆菌降低幽门螺杆菌负荷和改变肠道微生物群的疗效:一项双盲、安慰剂对照、随机试验。
Helicobacter. 2021 Dec;26(6):e12857. doi: 10.1111/hel.12857. Epub 2021 Oct 27.
9
The Effect of Probiotics Supplementation on Gut Microbiota After Helicobacter pylori Eradication: A Multicenter Randomized Controlled Trial.补充益生菌对幽门螺杆菌根除后肠道微生物群的影响:一项多中心随机对照试验。
Infect Dis Ther. 2021 Mar;10(1):317-333. doi: 10.1007/s40121-020-00372-9. Epub 2020 Dec 3.
10
Effect of probiotics during vonoprazan-containing triple therapy on gut microbiota in Helicobacter pylori infection: A randomized controlled trial.含 vonoprazan 的三联疗法中益生菌对幽门螺杆菌感染肠道微生物群的影响:一项随机对照试验。
Helicobacter. 2020 Jun;25(3):e12690. doi: 10.1111/hel.12690. Epub 2020 Mar 24.

引用本文的文献

1
The impact of infection and eradication therapies on gut microbiota: a systematic review of microbial dysbiosis and its implications in gastric carcinogenesis.感染与根除疗法对肠道微生物群的影响:微生物失调及其在胃癌发生中的意义的系统评价
Front Cell Infect Microbiol. 2025 Jul 7;15:1592977. doi: 10.3389/fcimb.2025.1592977. eCollection 2025.
2
Polymicrobial interactions of and its role in the process of oral diseases.[具体微生物名称]的多微生物相互作用及其在口腔疾病过程中的作用。 需注意,原文中“Polymicrobial interactions of and”表述不完整,缺少具体的微生物相关内容,以上译文是根据补充完整后的内容进行的翻译。
J Oral Microbiol. 2025 Feb 25;17(1):2469896. doi: 10.1080/20002297.2025.2469896. eCollection 2025.
3

本文引用的文献

1
Helicobacter pylori infection and risk of cardiovascular disease.幽门螺杆菌感染与心血管疾病风险。
Helicobacter. 2023 Jun;28(3):e12967. doi: 10.1111/hel.12967. Epub 2023 Mar 28.
2
Probiotics modulate gastrointestinal microbiota after eradication: A multicenter randomized double-blind placebo-controlled trial.益生菌可调节根除治疗后的胃肠道微生物群:一项多中心随机双盲安慰剂对照试验。
Front Immunol. 2022 Nov 8;13:1033063. doi: 10.3389/fimmu.2022.1033063. eCollection 2022.
3
[Research Progress in the Relationship Between and Dental Caries].
Alters Gut Microbiota and Metabolites Composition to Improve High Starch Metabolism in .
改变肠道微生物群和代谢物组成以改善……中的高淀粉代谢
Animals (Basel). 2025 Feb 18;15(4):583. doi: 10.3390/ani15040583.
4
Targeting Through the "Muco-Microbiotic Layer" Lens: The Challenge of Probiotics and Microbiota Nanovesicles.从“黏液-微生物层”视角看靶向性:益生菌与微生物群纳米囊泡面临的挑战
Nutrients. 2025 Feb 3;17(3):569. doi: 10.3390/nu17030569.
5
Current research status and trends of potassium-competitive acid blockers in the treatment of acid-related diseases: a bibliometric analysis.钾离子竞争性酸阻滞剂治疗酸相关性疾病的研究现状与趋势:一项文献计量学分析
Front Pharmacol. 2025 Jan 7;15:1477633. doi: 10.3389/fphar.2024.1477633. eCollection 2024.
6
Impacts of Helicobacter pylori infection and eradication on gastrointestinal microbiota: An up-to-date critical review and future perspectives.幽门螺杆菌感染与根除对胃肠道微生物群的影响:最新批判性综述与未来展望
Chin Med J (Engl). 2024 Dec 5;137(23):2833-2842. doi: 10.1097/CM9.0000000000003348. Epub 2024 Nov 6.
7
Evaluation of efficacy and safety of LRa05 in the eradication of : a randomized, double-blind, placebo-controlled trial.LRa05 根除率的疗效和安全性评价:一项随机、双盲、安慰剂对照试验。
Front Immunol. 2024 Aug 21;15:1450414. doi: 10.3389/fimmu.2024.1450414. eCollection 2024.
[与龋齿关系的研究进展] (你原文中“and Dental Caries”前面应该还有其他内容,这里翻译的是现有给出文本的主体部分)
Sichuan Da Xue Xue Bao Yi Xue Ban. 2022 Sep;53(5):929-934. doi: 10.12182/20220960103.
4
Analysis of oral microbiota alterations induced by Helicobacter pylori infection and vonoprazan-amoxicillin dual therapy for Helicobacter pylori eradication.分析幽门螺杆菌感染引起的口腔微生物群改变和沃诺拉赞-阿莫西林双联疗法根除幽门螺杆菌的效果。
Helicobacter. 2022 Oct;27(5):e12923. doi: 10.1111/hel.12923. Epub 2022 Aug 29.
5
Nisin and Nisin Probiotic Disrupt Oral Pathogenic Biofilms and Restore Their Microbiome Composition towards Healthy Control Levels in a Peri-Implantitis Setting.乳酸链球菌素和含益生菌的乳酸链球菌素可破坏口腔致病生物膜,并在种植体周围炎环境中将其微生物群组成恢复到健康对照水平。
Microorganisms. 2022 Jul 1;10(7):1336. doi: 10.3390/microorganisms10071336.
6
Innate Immunity Crosstalk with : Pattern Recognition Receptors and Cellular Responses.先天免疫与:模式识别受体和细胞反应的相互作用。
Int J Mol Sci. 2022 Jul 8;23(14):7561. doi: 10.3390/ijms23147561.
7
Oral microbiota in human systematic diseases.口腔微生物群与人类系统性疾病。
Int J Oral Sci. 2022 Mar 2;14(1):14. doi: 10.1038/s41368-022-00163-7.
8
Pseudomembranous Colitis Caused by Haemophilus Parainfluenzae.副流感嗜血杆菌引起的假膜性结肠炎
Inflamm Bowel Dis. 2022 Mar 30;28(4):e55-e56. doi: 10.1093/ibd/izab293.
9
The oral microbiota and its role in carcinogenesis.口腔微生物群及其在致癌作用中的作用。
Semin Cancer Biol. 2022 Nov;86(Pt 3):633-642. doi: 10.1016/j.semcancer.2021.11.002. Epub 2021 Nov 4.
10
Impact of infection on gut microbiota.感染对肠道微生物群的影响。
World J Gastroenterol. 2021 Oct 7;27(37):6224-6230. doi: 10.3748/wjg.v27.i37.6224.